Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part2)

NCT07067723 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 122

Last updated 2025-07-16

No results posted yet for this study

Summary

The goal of this observational study is

* to better understand the dominant modes of transmission
* to estimate the extent of transmission among contacts by determining the secondary infection rate for human-to-human transmission at an individual level and identifying factors associated with secondary infections.
* to determine the proportion of asymptomatic or pauci-symptomatic infections.
* to characterize the incubation period of mpox and the duration of infectiousness, including reproduction numbers.
* to assess serological responses following confirmed infection.

Conditions

  • Monkeypox (Mpox)

Sponsors & Collaborators

  • Osaka Metropolitan University

    lead OTHER

Principal Investigators

  • Yasutoshi Kido, Professor · Osaka Metropolitan University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Democratic Republic of the Congo

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07067723 on ClinicalTrials.gov